SEC Filing Analysis: HEALTHEQUITY, INC. (HQY)

Executive Summary

• Trading Significance: Low
• Key Takeaway: An executive sold a small, pre-planned portion of their holdings, representing an insignificant fraction of the company's market capitalization and total shares outstanding.
• Market Impact: Neutral. The sale was executed under a Rule 10b5-1 plan, indicating it was pre-scheduled and not based on recent material non-public information.

Company Information

Field	Value
Company	HEALTHEQUITY, INC.
Ticker Symbol	HQY
CIK	0001428336
Industry	SERVICES-BUSINESS SERVICES, NEC

Insider Information

Field	Value
Name	Ladd Delano
CIK	0001683056
Title/Position	EVP, General Counsel
Relationship	Officer

Transaction Details

Field	Value
Form Type	4
Transaction Date	2025-10-20
Transaction Code	S (Open market or private sale of securities)
Security Type	Common Stock
Shares Involved	1,500
Price Per Share	$92.07
Total Value	$138,105
Shares Owned After	76,979
Ownership Type	Direct

Financial Impact Assessment

Transaction Materiality

Metric	Value
Transaction Value	$138,105
% of Market Cap	0.0017%
Shares Transacted	1,500
% of Shares Outstanding	0.0017%
Post-Transaction Ownership	76,979 shares (0.089% of outstanding)
Materiality Assessment	Low

Impact Evaluation

• Market Cap Context: The $138,105 transaction is negligible for a company with an $8.27 billion market capitalization. It does not represent a significant capital event for the insider or the company.
• Ownership Concentration: The sale represents a minor reduction in the insider's holdings, decreasing their ownership from approximately 78,479 shares to 76,979 shares. This sale constituted less than 2% of the insider's total position, indicating no significant change in conviction.
• Dilution Impact: Not applicable as this was a sale of existing shares, not an issuance of new equity.
• Transaction Significance: Based on the transaction's value being less than 0.1% of market cap and the shares transacted being less than 0.1% of shares outstanding, the trade is classified as having low significance.

Market Impact Analysis

Stock Impact Prediction

• Direction: Neutral
• Reasoning: The sale is too small to impact market sentiment. Furthermore, its execution under a 10b5-1 plan strips it of most informational value regarding the company's current performance or future outlook.

Volume & Sentiment

• Expected Volume Impact: Minimal. The 1,500 shares are a tiny fraction of typical daily trading volume for a multi-billion dollar company.
• Sentiment Indicator: Neutral. This is a routine, pre-planned transaction for portfolio management or liquidity purposes.

Investment Insights

Positive Market Indicators

• N/A. The filing does not provide positive indicators.

Risk Factors

• N/A. The filing does not present any new risk factors.

Key Takeaways

1. Low Materiality: The transaction size is insignificant relative to HealthEquity's market cap and the insider's total holdings.
2. Pre-Scheduled Sale: The sale was made pursuant to a Rule 10b5-1 trading plan, indicating it was planned in advance and is not a reaction to current events.
3. No Change in Conviction: The insider sold less than 2% of their stake, retaining a significant position in the company. This is not indicative of a loss of confidence.

Additional Context

Transaction Notes

• Special Circumstances: The filing explicitly notes the transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on June 12, 2025. This is a critical piece of context that reduces the sale's significance as an insider signal.